New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 31, 2014
08:41 EDTMDVNMedivation weakness a buying opportunity, says UBS
UBS said Medivation weakness from the PREVAIL presentation is a buying opportunity and said its Q4 urology survey indicates topline PREVAIL data will drive robust utilization. Shares are Buy rated with a $93 price target.
News For MDVN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 25, 2014
16:13 EDTMDVNMedivation to names Joseph Lobacki as Chief Commercial Officer
Subscribe for More Information
November 21, 2014
08:18 EDTMDVNMedivation management to meet with Deutsche Bank
Subscribe for More Information
November 20, 2014
08:14 EDTMDVNMedivation management to meet with UBS
Subscribe for More Information
November 19, 2014
07:09 EDTMDVNJefferies to hold a conference
2014 Global London Healthcare Conference is being held in London, England on November 19-20.
November 12, 2014
11:17 EDTMDVNLeerink major pharma & biotech analysts hold analyst/industry conference call
Subscribe for More Information
November 11, 2014
15:43 EDTMDVNLeerink major pharma & biotech analysts hold analyst/industry conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use